|

Sarantis: Good But Not Enough

What’s new? We talked to the company. We understand there is inflation / COGS pressure that could cost them as much as 200bps in gross margin terms, with management trying to increase prices as a counter measure. We estimate the target is to defend / maintain 2020 EBITDA of E63m. If successful, shares are trading 10x EBITDA 2021E.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   

Similar Posts